| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |